🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

FNIH President and CEO Julie L. Gerberding, MD, MPH, was honored to moderate a panel on women's health and generational health at the #GalienForum2024. View the full discussion: youtube.com/watch?v=HPSXv3… Thanks The Galien Foundation for this opportunity.

Are you going to ACR Convergence? AMP® AIM and AMP RA/SLE will be hosting five oral presentations, and three posters at the conference this year! Learn more about AMP® AIM here: ow.ly/AM1K50U6ZrI #ACR24 #FNIH #BridgestoBreakthroughs

Big problems need big solutions. AMP AIM unites industry, academia, and patients to take on autoimmune diseases. Watch the full-length video in the AMP AIM webpage banner: ow.ly/KtYX50U704T #FNIH #BridgestoBreakthroughs

Learn about advancements in virology research at the Norman P. Salzman Memorial Awards and Symposium on Dec. 5 at the Lipsett Auditorium in the NIH Clinical Center. Featured scientists will include Post-Doctoral Awardee Nagela Ghabdan Zanluqui, PhD, MS. web.cvent.com/event/24a20af4…

Learn about advancements in virology research at the Norman P. Salzman Memorial Awards and Symposium on Dec. 5 at the Lipsett Auditorium in the NIH Clinical Center. Featured scientists will include Post-Baccalaureate Awardee Walker Symonds-Orr. web.cvent.com/event/24a20af4…

A big thank-you from everyone at the FNIH to all our partners in public health. We appreciate all you do to strengthen our communities. #PHTYD! #FNIH #BridgestoBreakthroughs

The hope of transforming lives drives Howard Y. Chang, MD, PhD, and Vijay G. Sankaran, MD, PhD – who were recognized during the FNIH Awards Ceremony. Watch their discussion with FNIH President and CEO Julie L. Gerberding, MD, MPH. youtube.com/watch?v=dgWyUo… Vijay Sankaran

The FNIH is supporting team research that has led to a better understanding of the underlying biology of Alzheimer’s disease and is now translating into innovative solutions for improving patient outcomes. FNIH partners Joel Braunstein, C2N Diagnostics, and Diane Stephenson and

HOPE — it’s embedded in everything we do — from supporting innovative research to funding exceptional scientists. Make a gift to the FNIH on #GivingTuesday, and you will help accelerate and amplify medical breakthroughs that bring hope to millions. fnih.org/giving-tuesday/

Thank you to everyone who helped build bridges to breakthroughs on #GivingTuesday! Your support will accelerate medical research designed to bring life-changing solutions to those who need them most, and we are #grateful! Learn more: fnih.org/giving-tuesday/

The FNIH values our partnerships with amazing people like Parkinson’s advocate Dr. Soania Mathur, MD, who shares her insights and lived experiences to support our Accelerating Medicines Partnership® for Parkinson’s Disease and Related Disorders. brainandlife.org/articles/mothe… PD Avengers

What better time than the holidays to express our gratitude for our partners in government, academia, life science organizations, and patient advocacy. It takes all of us to make a difference. Learn more about our mission ://fnih.org/

A recent thematic issue of the Journal of Clinical and Translational Science highlights insights from the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) program. Launched at the onset of the COVID-19 pandemic, ACTIV brought together experts from the NIH, the

The #NIHCommonFund #ComplementARIE program has released a new #FundingOpportunity for a Coordinating Center and Data Hub. Learn how you can contribute to accelerating development of #NewApproachMethodologies: go.nih.gov/3MBEmGy.

The FNIH joins the nation today in honoring the life of former President Jimmy Carter. President Carter’s extensive legacy includes his work to improve the health of our nation and people around the world. Please take a moment today to honor this incredible legacy.

The FNIH Biomarkers Consortium’s Treatments Against RA and Effect on FDG PET-CT (TARGET Biomarker Study) project sought to evaluate the connection between rheumatoid arthritis therapies and cardiovascular disease risk. As the project comes to a close, Principal Investigators Drs.

Exciting news: The FDA has accepted the Qualification Plan for a urine biomarker panel to be used in conjunction with standard laboratory tests to indicate response to drug-induced injury to the kidneys. Learn more: fnih.org/news/urine-bio… Critical Path Institute (C-Path) NIDDK